1. Gindros G, Kantas I, Balatsouras DG, Kaidoglou A, Kandiloros D. Comparison of ultrasound turbinate reduction, radiofrequency tissue ablation and submucosal cauterization in inferior turbinate hypertrophy. Eur Arch Otorhinolaryngol. 2010; Nov. 267(11):1727–33.
Article
2. Hol MK, Huizing EH. Treatment of inferior turbinate pathology: a review and critical evaluation of the different techniques. Rhinology. 2000; Dec. 38(4):157–66.
3. Porter MW, Hales NW, Nease CJ, Krempl GA. Long-term results of inferior turbinate hypertrophy with radiofrequency treatment: a new standard of care? Laryngoscope. 2006; Apr. 116(4):554–7.
Article
4. Passali D, Lauriello M, Anselmi M, Bellussi L. Treatment of hypertrophy of the inferior turbinate: long-term results in 382 patients randomly assigned to therapy. Ann Otol Rhinol Laryngol. 1999; Jun. 108(6):569–75.
Article
5. Shah AN, Brewster D, Mitzen K, Mullin D. Radiofrequency coblation versus intramural bipolar cautery for the treatment of inferior turbinate hypertrophy. Ann Otol Rhinol Laryngol. 2015; Sep. 124(9):691–7.
Article
6. Lee KC, Hwang PH, Kingdom TT. Surgical management of inferior turbinate hypertrophy in the office: three mucosal sparing techniques. Oper Tech Otolayngol Head Neck Surg. 2001; Jun. 12(2):107–11.
Article
7. Fradis M, Golz A, Danino J, Gershinski M, Goldsher M, Gaitini L, et al. Inferior turbinectomy versus submucosal diathermy for inferior turbinate hypertrophy. Ann Otol Rhinol Laryngol. 2000; Nov. 109(11):1040–5.
Article
8. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001; Aug. 27(8):1099–106.
Article
9. Pomonis JD, Rogers SD, Peters CM, Ghilardi JR, Mantyh PW. Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci. 2001; Feb. 21(3):999–1006.
Article
10. Feng GF, Han ZL, Wang F, Sun BC, Dai ZY, Yang SZ, et al. Comparison of high-intensity focused ultrasound therapy under nasal endoscopy guidance versus first-line drug treatment in patients with persistent allergic rhinitis. Genet Mol Res. 2015; Aug. 14(3):9865–71.
Article
11. Kim JK, Cho SW, Kim H, Jo SC, Kim HG, Won TB, et al. Development of high-intensity focused ultrasound therapy for inferior turbinate hypertrophy. Clin Exp Otorhinolaryngol. 2022; May. 15(2):160–7.
Article
12. Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003; Sep. 76(909):590–9.
Article
13. Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004; Apr. 42(1–9):931–5.
14. Leslie TA, Kennedy JE. High-intensity focused ultrasound principles, current uses, and potential for the future. Ultrasound Q. 2006; Dec. 22(4):263–72.
Article
15. Wei H, Zhang Y, Shi L, Zhang J, Xia Y, Zang J, et al. Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis. Int J Med Sci. 2013; Nov. 10(13):1914–20.
Article
16. Zhong B, Li LK, Deng D, Du JT, Liu YF, Liu F, et al. Effect of high-intensity focused ultrasound versus plasma radiofrequency ablation on recurrent allergic rhinitis. Med Sci Monit. 2019; Sep. 25:6775–81.
Article
17. Kim CS, Moon BK, Jung DH, Min YG. Correlation between nasal obstruction symptoms and objective parameters of acoustic rhinometry and rhinomanometry. Auris Nasus Larynx. 1998; Jan. 25(1):45–8.
Article
18. Isaac A, Major M, Witmans M, Alrajhi Y, Flores-Mir C, Major P, et al. Correlations between acoustic rhinometry, subjective symptoms, and endoscopic findings in symptomatic children with nasal obstruction. JAMA Otolaryngol Head Neck Surg. 2015; Jun. 141(6):550–5.
Article